kmed Journal - Psychiatry

Kmed Journal of Psychiatry

Advancing Mental Health Through Evidence and Compassionate Care

Psychiatry stands at the intersection of neuroscience, human experience, and therapeutic relationship — where accurate diagnosis can be life-saving, where treatment combines biological and psychosocial interventions, and where destigmatization begins with evidence-based practice. Kmed journalof Psychiatry exists for the psychiatrists, mental health professionals, and researchers advancing care for people living with mental illness.

We publish original research, clinical case reports, treatment outcome studies, epidemiological investigations, and systematic reviews across the full breadth of psychiatric practice. Whether you are reporting outcomes from a community mental health program, documenting a treatment-resistant case, or evaluating psychopharmacological efficacy — if it advances how mental illness is understood, diagnosed, or treated, it belongs here. Every submission undergoes rigorous peer review, and every published article is freely accessible to the global mental health community.

Why publish with us?

Submit Your Manuscript – Share Knowledge

The Subject areas covered by the kmed Journals include (but are not limited to)

  • General & Basic Psychiatry - Pharmacokinetics. Pharmacodynamics, Receptor Mechanisms. Drug Metabolism. Pharmacogenomics
  • Autonomic & Cardiovascular Psychiatry - Drugs Acting On The Autonomic Nervous System, Antihypertensives, Antiarrhythmics, Vasodilators, Anticoagulants, Antiplatelet Agents
  • Central Nervous System Psychiatry - Analgesics, Antiepileptics, Antipsychotics, Antidepressants, Anxiolytics, Neuroprotective Agents
  • Endocrine Psychiatry - Antidiabetic Drugs, Thyroid And Adrenal Agents, Reproductive Psychiatry, Bone Metabolism Drugs
  • Respiratory & Renal Psychiatry - Bronchodilators, Anti-Asthmatic, Diuretics, Drugs In Renal Disorders
  • Gastrointestinal Psychiatry - Acid Suppressants, Antiemetics, Prokinetics, Laxatives, Antidiarrheals, Drugs For IBD And Liver Disease
  • Antimicrobial Psychiatry - Antibacterial, Antiviral, Antifungal, Antiparasitic Agents: Antimicrobial Resistance: Stewardship Programs
  • Cancer Chemotherapy & Immunopharmacology - Cytotoxic Drugs. Targeted Therapy. Immunotherapy, Monoclonal Antibodies, Checkpoint Inhibitors
  • Toxicology & Pharmacovigilance - Drug Toxicity. Adverse Drug Reactions. Poisoning Management, Pharmacovigilance Systems, Regulatory Science
  • Clinical Psychiatry & Therapeutics - Rational Prescribing. Drug Interactions, Therapeutic Drug Monitoring, Clinical Trials, Personalized Medicine
  • Molecular & Biochemical Psychiatry - Signaling Pathways. Drug-Receptor Interactions, Enzyme Inhibition, Pharmacogenetics
  • Biologics & Biosimilars - Vaccines, Hormones. Growth Factors. Monoclonal Antibodies. Regulatory Perspectives
  • Herbal & Traditional Medicine - Phytopharmacology. Herbal Drug Evaluation, Integrative Medicine, Safety And Efficacy Studies
  • Pharmacoeconomics & Pharmacoepidemiology - Cost-Effectiveness, Access To Medicines, Drug Utilization Research, Health Policy Implications
  • Advances In Drug Development - High-Throughput Screening. Nanotechnology, Novel Drug Delivery Systems. AI In Drug Discovery
  • Educational Psychiatry - Innovations In Teaching Psychiatry. Simulation, E-Learning. Competency-Based Approaches

Editorial Board

Updating Soon